Lyell Immunopharma, Inc. · NASDAQ:LYEL

Lyell Immunopharma, Inc. shareholders

As of Sep 30, 2026, 99 institutions reported holding Lyell Immunopharma, Inc., 49.2% of its shares. Largest: ARCH Venture Management, LLC, GSK plc and Vanguard. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Lyell Immunopharma, Inc.ChangeFiled
ARCH Venture Management, LLC3.25M13.2%no changeNov 16, 2026
GSK plc1.51M6.2%no changeNov 5, 2026
Vanguard916K3.7%−60,466Nov 13, 2026
BlackRock799K3.3%+74,715Nov 13, 2026
Orland Properties Ltd755K3.1%no changeNov 13, 2026
Almitas Capital LLC448K1.8%−133KNov 16, 2026
AQR Capital Management LLC346K1.4%newNov 16, 2026
venBio Partners LLC338K1.4%no changeNov 16, 2026
Alphabet Inc.293K1.2%no changeNov 5, 2026
Opaleye Management Inc.291K1.2%−52,672Nov 16, 2026

Lyell Immunopharma, Inc. insider trades